
Cytimmune Sciences
Get Full AccessDescription
- CytImmune is a global leader in the field of cancer nanomedicine. The company has more than 60 issued and pending patents for its colloidal gold nanotechnology in the United States, European Union, Japan and Canada. We have successfully completed a Phase I clinical trial of CYT-6091 the first in a series of nanomedicines based on our Aurimune nanomedicine platform. For more information about Aurimune or CytImmune, please visit our website, http://CytImmune.com. To read our opinions on topics relevant to cancer patients and their families, health care professionals, and the research community, visit our blog: http://CytImmune.Blog
-
Headquarters:15010 Broschart Road , Rockville, Maryland, United States
More -
Phone Number: +1 301-825-3041
-
Website: https://www.cytimmune.com
-
Employees:6
-
Revenue:$1 - 10M
-
Legal Name:Cytimmune Sciences
-
Cytimmune Sciences's Social Media
-
Is this data correct?
-
| NAICS Code: 541713 |
Show More
Frequently Asked Questions regarding Cytimmune Sciences
-
Where are Cytimmune Sciences's Headquarters?
Cytimmune Sciences's Headquarters are in 15010 Broschart Road ,Rockville,Maryland,United States
-
What is Cytimmune Sciences's phone number?
Cytimmune Sciences's phone number is +1 301-825-3041
-
What is Cytimmune Sciences's official website?
Cytimmune Sciences's official website is https://www.cytimmune.com
-
What is Cytimmune Sciences's Revenue?
Cytimmune Sciences's revenue is $1 - 10M
-
What is Cytimmune Sciences's NAICS code?
Cytimmune Sciences's NAICS code is 541713
-
How many employees are working in Cytimmune Sciences
Cytimmune Sciences has 6 employees
-
What is Cytimmune Sciences's Industry?
Cytimmune Sciences is in the industry of Biotechnology
-
Who is Cytimmune Sciences's CEO?
Cytimmune Sciences's CEO is Saba Malak